Skip to content
Mestranol
Enovid, Norethin 1/50m, Norinyl, Ortho-novum, Ovulen (mestranol) is a small molecule pharmaceutical. Mestranol was first approved as Ovulen on 1982-01-01.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Ethynodiol diacetate
+
Mestranol
Tradename
Company
Number
Date
Products
OVULENG.D. SearleN-016029 DISCN1982-01-01
1 products
OVULEN-21G.D. SearleN-016029 DISCN1982-01-01
1 products
OVULEN-28G.D. SearleN-016705 DISCN1982-01-01
1 products
Hide discontinued
Mestranol
+
Norethindrone
Tradename
Company
Number
Date
Products
NORINYL 1+50 21-DAYAllerganN-013625 DISCN1982-01-01
1 products
NORINYLAllerganN-013625 DISCN1982-01-01
1 products
NORINYL 1+50 28-DAYAllerganN-016659 DISCN1982-01-01
1 products, RLD
NORINYL 1+80 21-DAYG.D. SearleN-016724 DISCN1982-01-01
1 products
NORINYL 1+80 28-DAYG.D. SearleN-016725 DISCN1982-01-01
1 products
ORTHO-NOVUM 1/50 28Johnson & JohnsonN-016709 DISCN1982-01-01
1 products
ORTHO-NOVUM 10-21Johnson & JohnsonN-012728 DISCN1982-01-01
1 products
ORTHO-NOVUM 1/50 21Johnson & JohnsonN-012728 DISCN1982-01-01
1 products
ORTHO-NOVUM 2-21Johnson & JohnsonN-012728 DISCN1982-01-01
1 products
ORTHO-NOVUM 1/80 21Johnson & JohnsonN-016715 DISCN1982-01-01
1 products
ORTHO-NOVUM 1/80 28Johnson & JohnsonN-016715 DISCN1982-01-01
1 products
Hide discontinued
Mestranol
+
Norethynodrel
Tradename
Company
Number
Date
Products
ENOVIDG.D. SearleN-010976 DISCN1982-01-01
2 products
ENOVID-EG.D. SearleN-010976 DISCN1982-01-01
1 products
ENOVID-E 21G.D. SearleN-010976 DISCN1982-01-01
1 products
ENOVIDG.D. SearleN-010976 DISCN1982-01-01
1 products
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameMESTRANOL
INNmestranol
Description
Mestranol is a terminal acetylenic compound that is (17alpha)-17-ethynylestra-1(10),2,4-triene substituted by a methoxy group at position 3 and a hydroxy group at position 17. It has a role as a prodrug and a xenoestrogen. It is a 17beta-hydroxy steroid, a terminal acetylenic compound and an aromatic ether. It is functionally related to a 17beta-estradiol.
Classification
Small molecule
Drug classestrogens
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OC)ccc4[C@H]3CC[C@@]21C
Identifiers
PDB—
CAS-ID72-33-3
RxCUI6782
ChEMBL IDCHEMBL1201151
ChEBI ID6784
PubChem CID6291
DrugBankDB01357
UNII IDB2V233XGE7 (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 1,012 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
24 adverse events reported
View more details